- Home
- HMST vs XBIT Comparison
HMST vs XBIT Comparison
Compare HMST & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- XBIT
- Stock Information
- Founded
- HMST 1921
- XBIT 2005
- Country
- HMST United States
- XBIT United States
- Employees
- HMST 819
- XBIT N/A
- Industry
- HMST Major Banks
- XBIT Pharmaceuticals and Biotechnology
- Sector
- HMST Finance
- XBIT Health Care
- Exchange
- HMST Nasdaq
- XBIT Nasdaq
- Market Cap
- HMST 194.6M
- XBIT 194.5M
- IPO Year
- HMST 2012
- XBIT 2015
- Fundamental
- Price
- HMST $10.32
- XBIT $3.25
- Analyst Decision
- HMST Buy
- XBIT
- Analyst Count
- HMST 2
- XBIT 0
- Target Price
- HMST $14.75
- XBIT N/A
- AVG Volume (30 Days)
- HMST 176.5K
- XBIT 52.0K
- Earning Date
- HMST 01-27-2025
- XBIT 03-14-2025
- Dividend Yield
- HMST N/A
- XBIT N/A
- EPS Growth
- HMST N/A
- XBIT N/A
- EPS
- HMST N/A
- XBIT N/A
- Revenue
- HMST $75,702,000.00
- XBIT N/A
- Revenue This Year
- HMST N/A
- XBIT N/A
- Revenue Next Year
- HMST $9.32
- XBIT N/A
- P/E Ratio
- HMST N/A
- XBIT N/A
- Revenue Growth
- HMST N/A
- XBIT N/A
- 52 Week Low
- HMST $8.09
- XBIT $3.25
- 52 Week High
- HMST $16.10
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- HMST 47.32
- XBIT 26.88
- Support Level
- HMST $9.61
- XBIT $3.40
- Resistance Level
- HMST $10.58
- XBIT $3.69
- Average True Range (ATR)
- HMST 0.56
- XBIT 0.20
- MACD
- HMST 0.02
- XBIT 0.05
- Stochastic Oscillator
- HMST 53.42
- XBIT 3.85
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.